Development of an integral assessment approach of health status in patients with obstructive airway diseases: The CORONA study

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 2413-2422

  van den Akker, Edmée F M M ^a   van ‘t Hul, Alex J ^b   Chavannes, Niels H ^c   Braunstahl, Gert Jan ^a   van Bruggen, Alie ^a   Rutten van Mölken, Maureen P M H ^d   in ‘t Veen, Johannes C C M ^a  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Comprehensive assessment; Diagnostic pathway; Health status; Integrated care; Shared decision making

Indexed keywords

ADULT; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; GENERAL HEALTH STATUS ASSESSMENT; HUMAN; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; METRONOME PACED HYPERVENTILATION TEST; NIJMEGEN CLINICAL SCREENING INSTRUMENT; OXYGEN SATURATION; OXYGEN TENSION; QUALITY OF LIFE; RADIOALLEGROSORBENT TEST; RADIOIMMUNOASSAY; REVIEW; SMOKING; ACTIMETRY; CLINICAL DECISION MAKING; CLINICAL PATHWAY; COST OF ILLNESS; DELPHI STUDY; DEVICES; HEALTH STATUS; HEALTH STATUS INDICATOR; INTEGRATED HEALTH CARE SYSTEM; LUNG; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PATIENT PARTICIPATION; PREDICTIVE VALUE; PROGNOSIS; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; SECONDARY HEALTH CARE; TIME FACTOR;

ACTIGRAPHY; ACTIVITIES OF DAILY LIVING; ASTHMA; CLINICAL DECISION-MAKING; COST OF ILLNESS; CRITICAL PATHWAYS; DELIVERY OF HEALTH CARE, INTEGRATED; DELPHI TECHNIQUE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LUNG; MOTOR ACTIVITY; PATIENT PARTICIPATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SECONDARY CARE; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84946838318     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S90680     Document Type: Review

References (34)

1. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for Diagnosis, Management and Prevention of COPD; 2014. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed February 3, 2015.
2. Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44:1521-1537.
3. Vercoulen JH. A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour. Chron Respir Dis. 2012;9:259-268.
4. Wechsler ME. Managing asthma in primary care: putting new guideline recommendations into context. Mayo Clin Proc. 2009;84:707-717.
5. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273:59-65.
6. Vercoulen JH, Daudey L, Molema J, et al. An integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med. 2008;15:263-279.
7. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-e64.
8. Long Alliantie Nederland. Zorgstandaard COPD [Care Standard COPD]. Amersfoort, The Netherlands: Long Alliantie Nederland; 2010. Dutch.
9. Nici L, ZuWallack R; American Thoracic Society Subcommittee on Integrated Care of the CP. An official American Thoracic Society workshop report: the Integrated Care of The COPD Patient. Proc Am Thorac Soc. 2012;9:9-18.
10. Agusti A, MacNee W. The COPD control panel: towards personalised medicine in COPD. Thorax. 2013;68:687-690.
11. Reuben DB, Tinetti ME. Goal-oriented patient care - an alternative health outcomes paradigm. N Engl J Med. 2012;366:777-779.
12. Global Initiative for Asthma. Global strategy for asthma management and prevention; 2011. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report2011_May4.pdf. Accessed October 9, 2015.
13. Effing TW, Bourbeau J, Vercoulen J, et al. Self-management programmes for COPD: moving forward. Chron Respir Dis. 2012;9(1):27-35.
14. Lodewijckx C, Decramer M, Sermeus W, Panella M, Deneckere S, Vanhaecht K. Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation. Trials. 2012;13:229.
15. Tsiachristas A, Cramm JM, Nieboer AP, Rutten-van Molken MP. Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants. Cost Eff Resour Alloc. 2014;12:17.
16. Long Alliantie Nederland. Zorgstandaard Astma [Care Standard Asthma]. Amersfoort, The Netherlands: Long Alliantie Nederland; 2012. Dutch.
17. Jones P, Miravitlles M, van der Molsen T, Kulich K. Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697-709.
18. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11:79.
19. Spruit MA. Pulmonary rehabilitation. Eur Respir Rev. 2014;23:55-63.
20. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica, CA: RAND. Available from: http://www.rand.org/publications/MR/MR1269/. Accessed October 10, 2015.
21. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728-735.
22. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20:539-544.
23. Lv N, Xiao L, Camargo CA Jr, et al. Abdominal and general adiposity and level of asthma control in adults with uncontrolled asthma. Ann Am Thorac Soc. 2014;11:1218-1224.
24. Rang LC, Murray HE, Wells GA, Macgougan CK. Can peripheral venous blood gases replace arterial blood gases in emergency department patients? CJEM. 2002;4:7-15.
25. van Dijk WD, van Bemt L, van den Haak-Rongen S, et al. Multidimensional prognostic indices for use in COPD patient care. Respir Res. 2011;12:151.
26. Gelb AF, Gutierrez CA, Weisman IM, Newsom R, Taylor CF, Zamel N. Simplified detection of dynamic hyperinflation. Chest. 2004;126:1855-1860.
27. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-615.
28. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586.
29. van Dam van Isselt EF, Spruit M, Groenewegen-Sipkema KH, Chavannes NH, Achterberg WP. Health status measured by the Clinical COPD Questionnaire (CCQ) improves following post-acute pulmonary rehabilitation in patients with advanced COPD: a prospective observational study. NPJ Prim Care Respir Med. 2014;24:14007.
30. Peters JB, Rijssenbeek-Nouwens LH, Bron AO, et al. Health status measurement in patients with severe asthma. Respir Med. 2014;108:278-286.
31. Van Remoortel H, Raste Y, Louvaris Z, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One. 2012;7:e39198.
32. Sundh J, Stallberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD. 2011;8:173-181.
33. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147:832-838.
34. Huber M, Knottnerus JA, Green L, et al. How should we define health? BMJ. 2011;343:d4163.